Aim: Glycosmis parva leaf extract was reported to have cytotoxicity and antiinflammatory activities with the reduction of COX2 expression in vitro. This study aimed to investigate the effect of ethyl acetate extracts from leaves of G parva (GPE) on human colorectal cancer expressing COX2-HT29 cells and its underlying mechanisms of action. Methods: Cytotoxicity of 6.25-100 µg/mL GPE against HT29 was done by resazurin reduction assay. Induction of apoptosis was determined by AnnexinV/FITC and PI staining. Anti-proliferative study was performed using automated cell counter. Cell cycle pattern was analyzed by PI staining. The expression of Bcl-2 family proteins was examined by qPCR. COX2 expression was determined by RT-PCR. Results: GPE was cytotoxic to HT29 in a dose-dependent manner with IC 50 values 69.50, 55.86, and 49.04 µg/mL at 24, 48, and 72 h, respectively. GPE at 50-100 µg/mL significantly induced HT29 apoptosis. At 25-100 µg/mL, it dose-dependently inhibited HT29 cell proliferation. GPE at 100 µg/mL caused G2M accumulation. It changed the expression of Bcl-2 family proteins. It also significantly decreased COX2 expression at 25-100 µg/mL. Conclusion: GPE exhibited cytotoxic activity, induction of apoptosis, inhibition of cell proliferation and arrest cell cycle in HT29 cells. The underlying mechanisms may involve decrease in COX2 expression and changes in the expression of Bcl-2 family proteins and which favor cancer cell death. Patients with advanced pancreatic cancer are associated with veous thromboembolism (VTE). tissue factor (TF) is a biomarker in initiation of thrombosis and cancer progression. The aim of this study was to investigate the pathological role of TF/ protease-activated receptor-2 (PAR-2) signaling in pancreatic cancer. Methods: First, effects of PAR-2 activation on gene expression investigated by microarray analysis. Then, PAR-2-mediated genes were confirmed by RT-PCR and Western blot analysis. VEGF-A levels were detected by a ELISA kit. For in vitro angiogenesis assay, HUVECs proliferation was measured by crystal violet staining; tube formation was examined by Matrigel tube formation assay. Results: According to the results of microarray assay, TF/PAR-2 signaling regulated an oncogenic pathway through increasing both HIF-1α and HIF-2α, resulting in enhanced transcription of TGF-α. Downregulation of HIF-α by siRNA or YC-1 resulted in depleted levels of TGF-α protein. Furthermore, the culture medium from PAR-2-treated pancreatic cancer cells enhanced HUVEC proliferation and tube formation, which was blocked by the MEK inhibitor PD98059. We also found that activated PAR-2 enhanced tumor angiogenesis through the release of VEGF from cancer cells, independent of the HIF pathways. Conclusion: The TF/PAR-2 signaling induced human pancreatic cancer progression through the induction of TGF-α expression by HIF-α, as well as through MEK/VEGF-mediated angiogenesis, and it plays a role in the interaction between cancer progression and cancer-related thrombosis. Keywords: protease-activated receptor-2 (PAR-2); tissue factor (TF); HIF; VEGF; pancreatic cancer S1. In this study, effect of expression of the aryl hydrocarbon receptor nuclear translocator (ARNT) on the development of acquired drug resistance in cancer cells was investigated. Methods: cisplatin-sensitive or acquired resistant cancer cells were treated with cisplatin for a period of time in ARNT knockdown or overexpression conditions. The cell survival and apoptotic markers such as expression of p53, caspase-3 activation and DNA fragmentation were then detected by CCK-8 assay, MTT assay, flow cytometric and Western blot analysis. The effect of ARNT on MDR1 expression was determined by luciferase reporter analysis, RT-PCR and Western blot analysis. In addition, the cooperation between Sp1 and ARNT in the regulation of MDR1 expression was examined by DAPA and luciferase reporter analysis. In a xenograft analysis of SCID mice, the effect of cisplatin on ARNTdeficient c4 tumors and ARNT-containing vT2 tumor formation was studied.
S1.7
Anticancer effects of Gekko ethanol extract in human hepatocellular carcinoma HepG2 cells and in H22 bearing mice Chao-chu CUI, Jian-gang WANG, Leng-xin DUAN, Xin-li XU. The Key Laboratory of Pharmacology and Medical Molecular Biology, Medical College, Henan University of Science and Technology, Luoyang 471003,China Aim: To explore the anticancer effects and underlying mechanism of Gekko ethanol extract (GEE) in vitro and in vivo. Methods: MTT assay was employed to evaluate the anti-proliferative effect of GEE in vitro. Hoechst 33258 fluorescence staining was performed to observe morphologic changes nucleus of HepG2 cells; Antitumor properties of GEE in vivo were tested in H22 tumor bearing mice. Tumor weight of each mouse was evaluated at the end. The expression levels of IL-6 and TNF-α were analyzed by ELISA assay. Western blotting analysis was carried out to detect the expression levels of caspase-3 and VEGF in tumors. Results: GEE has anti-proliferative effect in a time-dose dependent manner, with inducing typical apoptotic morphological changes ability in HepG2 cells. GEE resulted in significant decrease in tumor weight. The expression levels of IL-6 and VEGF were downregulated, whereas TNF-α and caspase-3 were increased after treatment of GEE in vivo. Conclusion: Taken together, these findings suggest GEE has significant anti-liver cancer activities both in vitro and in vivo, which may be involved in antiangiogenesis and induction of apoptosis. Keywords: Gekko ethanol extract; apoptosis; antiangiogenesis; hepatocellular cancer S1. E-mail: gyzh@zzu.edu.cn Aim: To investigate whether 12-O-tetradecanoylphorbol-13-acetate (TPA) can increase the sensitivity of cisplatin on human lung adenocarcinoma cisplatinsensitive cell line A549 and cisplatin-resistant cell line A549/CP. Methods: MTT assay was used to observe cell proliferation after treating by TPA alone or in combination with cisplatin. Intracellular cisplatin accumulation was measured by flameless automic absorption spectroscopy. Specific activities of Na + , K + -ATPase were detected according to the procedure of Na + , K + -ATPase activity detection kit. Assesment of Na + , K + -ATPase α and β subunits was done by Western blotting. Results: TPA at 8.1 nmol/L or lower didn't affect the cells' proliferation. TPA decreased IC 50 of cisplatin by 77% in A549cells and 69% in A549/CP cells at 8.1 nmol/L after 96 h respectively. Intracellular cisplatin accumulation was increased after pretreated with TPA for 72 h in both cell lines. However, pretreatment with Na (PGE 2 ) has been shown to play an important role in tumor development and progression. PGE 2 mediates its biological activity by binding any one of four prostanoid receptors (EP 1 through EP 4 ). The present study was designed to investigate the role of the EP 2 receptor during proliferation and apoptosis of human HepG2 and SMMC-7721 hepatoma cell lines and the effect of paeoniflorin, a monoterpene glucoside. Methods: The proliferation of HepG2 and SMMC-7721 cells was determined by methyl thiazolyl tetrazolium (MTT) after exposure to the selective EP 2 receptor agonists butaprost and paeoniflorin. Apoptosis of HepG2 and SMMC-7721 cells were also quantified by flow cytometry with annexin V-fluorescein isothiocyanate (FITC) and propidium iodide (PI) staining. The expression levels of Bcl-2 and Bax were quantified by western blotting and immunohistochemistry. The expression of the EP 2 receptor and cysteine-aspartic acid protease (caspase)-3 was determined by Western blotting. Results: Butaprost significantly increased proliferation in HepG2 and SMMC-7721 cells. Paeoniflorin significantly inhibited HepG2 and SMMC-7721 cells proliferation stimulated by butaprost at multiple time points (24, 48, and 72 h) . Paeoniflorin induced apoptosis in HepG2 and SMMC-7721 cells that was quantified by annexin-V and PI staining.
Our results indicate that the expression of the EP 2 receptor, Bcl-2 was significantly increased, Bax, cleaved caspase-3 was decreased in HepG2 and SMMC-7721 cells after stimulated by butaprost. Paeoniflorin significantly decreased the EP 2 receptor, Bcl-2 expression and increased Bax and caspase-3 activation in HepG2 and SMMC-7721 cells addition with butaprost. Conclusion: Our results suggest that the PGE 2 receptor subtype EP 2 may play a vital role in cell survival in both HepG2 and SMMC-7721 cells. Paeoniflorin, which may be a promising agent in the treatment of liver cancer, induced apoptosis in HCC cells by downregulating EP 2 expression and increased the Bax-to-Bcl-2 ratio, thus up-regulating the activation of caspase-3. Keywords: paeoniflorin; butaprost; EP 2 ; hepatocellular carcinoma; apoptosis; caspase-3 Acknowledgements: This work was supported by grants from Specialized Research 
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Anti-tumor effect of three kinds of traditional chinese medicine formula on S 180 -bearing mice Zhi-ping HU, Xing-feng CHANG, Chun-hua SONG, Bao-ying LUO, Jie WANG, Li-ming Autophagy is a conserved catabolic pathway in which autophagosomes fuse with lysosomes for protein degradation and amino acid recycling. The initiation of npg autophagy is triggered by a lipid kinase (PI3KC3) signaling complex, consisting of Vps34, Vps15, and beclin1. Treatment of breast cancer cells with anti-tumor drugs inducing the metabolic and protein-misfolding stress results in heat shock proteins (hsp) expression and induction of autophagy to avoid cell death. Hsp70 is a stress-activated multifunctional chaperone containing cytoprotective function to inhibit cell apoptosis and cause resistance in breast and other cancers. Suppression of Hsp70 sensitizes cancer cells to chemotherapy. In our previous studies, treatment of breast cancer MCF-7 cells with HDAC inhibitor LBH589 induces autophagosome formation companied by hyperacetylation of hsp70 which enhances the stability and activity of VPS34, via kap-1 dependent sumoylation, leading to the formation of VPS34-Beclin1 complex.
Recently, Chloroquine, a widely used antimalarial agent, has been revealed to have promising effects on cancer treatment in clinical trials. Here, we report that co-treatment with LBH589 and chloroquine or hsp70 inhibitor Pifithrin-α (PFTα) significantly enhanced lethality of breast cancer MB-231, MB-468, and MCF-7 cells. We found that both chloroquine and PFTα inhibited autophagy activation and hsp70 expression following LBH589-induced autophagy protecting cell from apoptosis. Importantly, combinatorial treatment with LBH-589 with hsp70 inhibitor chloroquine or PFTα resulted in the abrogation of LBH589-induced interaction of hsp70 with VPS34, and the sumoylation and activity of Vps34. Both chloroquine and PFTα targeting Hsp70 significantly delayed breast cancer growth in vivo.
Our findings demonstrate that a new strategy using agent, such as chloroquine and PFTα, cotargeting hsp70 and Vps34 has the potential benefits to improve treatment outcomes in cancer.
S1.21
The 
Aim:
In recent years, the use of natural plant products has intensively attracted attention among clinicians and the public for the prevention and treatment of various chronic diseases. Chaenomeles speciosa (Sweet) Nakai is one of the natural plants with high medicinal and dietary value, and comprised of amounts of various effective ingredients such as the total flavonoids, organic acid, and so forth, is originally from Anhui, Hubei and Sichuan of China. This investigation evaluates anti-tumor activity and its mechanism of total flavonoids from Chaenomeles speciosa (Sweet) Nakai (FLC). Methods: The sarcoma 180 (S180)-bearing mice were used to study potential anti-cancer activity of FLC. The tumor size, survival rate and immune responses were measured in S180 solid and ascites tumor. Molecular screening model of PD-1/PD-L1 was established and the FLC was used to investigate the inhibite activity. Lymphocyte proliferation was also assayed for the extract FLC. Results: Our data showed that the FLC could significantly inhibit the tumor growth and prolong the survival time in the S180 tumor bearing mice. The lymphocyte proliferation assay showed that the FLC could improve the specific lymphocyte proliferation. In the S180 ascites, the FLC enhanced tumor infiltrating lymphocytes (TIL) and inhibited programmed death-1-ligand 1 (PD-L1) expression. Using molecular binding assay FLC could inhibit the binding of PD-L1 to PD-1. Conclusion: These results suggest that FLC exhibited anti-cancer and immunomodulatory activities, which improved natural and adaptive immune functions, such as interfering PD-1/PD-L1 pathway. Keywords: Chaenomeles speciosa (Sweet) Nakai; flavonoids; anti-cancer activity; immune regulation S1. Aim: Sulfur mustard (SM) can cause DNA damage and the activation of poly(ADPribose)polymerase (PARP). PARP inhibitor has been reported some protective effects in SM skin injury in vivo and in vitro. S003 is a PARP inhibitor synthesized by our institute. The aim of our study is to observe the effect of S003 in SM treated HaCaT cells and in SM induced mouse ear vesicant model (MEVM). Methods:
HaCaT cells were exposed to SM 30 min and then cultivated in SM free medium with or without S003 for up to 6 h. Cell viability, NAD + and PAR contents, the percentage of apoptotic and necrotic cells, and caspase 3 activity were assayed. SM in propylene glycol (0.16 and 0.64 mg/ear) was applied to the right ear of KM mouse, S003 was ip at dose of 200 mg/kg. Results: The amount of intracellular PAR were decreased to 69% after exposed to 1000 mol/L SM about 30 min, and it was reduced to 11% by combined treatment with S003. NAD + levels were diminished to 11% and cell viability were reduced to 45% after 6 h exposure of SM. While, treatment with S003 increased the NAD + levels to 83% and cell viability to 78%.
Meanwhile, the recuction of S003 on apoptosis and necrosis was also observed.
While after 6 h exposure of 100 mol/L SM, S003 did not affect the cell viability, but significantly increased percentage of apoptotic and necrotic cells, and caspase 3 activation. In the MEVM, S003 significantly reduced relative ear weight about 30% in the 0.64 mg/ear SM injury, but showed no protective effect in the 0. Aim: 3-bromopyruvate (3-BrPA) has antineoplastic activity on malignant cells. In this study, we investigated the toxicity of 3-BrPA on two breast cancer cell lines. Methods: The intracellular ATP level was measured by the ATP Assay Kit. Cell viability was measured using MTT assay. Cell death was assessed by flow cytometry with propidium iodide (PI) staining or PI/Annexin V staining. The ultrastructural details of two breast cancer cells treated with vehicle DMSO, 3-BrPA, or 3-BrPA plus caspase inhibitor (z-VAD-fmk) were analyzed by electron microscopy (EM). Small interfering RNA mediated RIP1 and RIP3 knockdown, and the expression of RIP1 and RIP3 were analyzed by Western blot. Results: 320 μmol/L 3-BrPA had significant toxicity on MDA-MB-231 cells, whereas no obvious effect was observed in MDA-MB-435 cells. In MDA showed that after exposure of compound GA alone or in combination with ADM to MCF-7/Adr, the expression of mRNA of Bcl-2, mutant p53 were down-regulated; the expression of mRNA of bax and caspase-3 were up-regulated, but effects on the mRNA expression of MRP and LRP were unclear. Western blot results showed that GA alone and in combination with ADM could down-regulate the protein expression of Bcl-2, mutant p53 and LRP, and up-regulated the protein expression of bax at the same time, but treatment of GA alone and in conjunction with ADM had no obvious effect on the protein expression of MRP of MCF-7/Adr. Conclusion: Either treatment of MCF-7/Adr with GA alone or GA in combined with ADM, can significantly induced apoptosis of MCF-7/Adr cells. But GA does not always enhance the effect of ADM on cell apoptosis, the reason is not unclear. The mechanism of apoptosis of MCF-7/ Adr induced by GA alone or GA in combined with ADM is involved in downrengulation of the expression of bcl-2, mutant p53 and LRP, up-regulation of the expression of bax. But whether related to the effect on the expression of MRP and caspase-3 remain still uncertain. Keywords: compound GA; tumor; multi-drug resistance; apoptosis Aims: Jaridonin, a novel diterpenoid from Rabdosia rubescens has been shown previously to inhibit proliferation of esophageal squamous cancer cells (ESCC) through G 2 /M phase cell cycle arrest. However, the involved mechanism is not fully understood. Methods: Cell cycle was analysed by flow cytometry. The related protein expressions were determined by Western blot. Results: In this study, we found that the cell cycle arrest by Jaridonin was associated with the increased expression of ATM and phosphorylation of Cdc2 at Tyr15. Jaridonin also resulted in enhanced phosphorylation of Cdc25C via activation of checkpoint kinases Chk1 and Chk2, as well as in increased phospho-H2A.X (Ser139). We also found that the increased activation of ATM is related to the DNA damage caused by Jaridonin. Furthermore, Jaridonin-mediated alterations in cell cycle arrest were significantly Chang 443002, China Aim: Gamma-linolenic acid (GLA) was reported had cytotoxic effect on gliobastoma cells. In this study, we investigated the direct cytotoxic action of GLA against gliobastoma cells and the underlying mechanisms. Methods: Glioblastoma cells (GBM2) were treated with 25, 75, and 150 μmol/L GLA for 24 h and the proliferation activity of cells were detected by MTT assay. The apoptosis effect and the change of cell cycle were determined by flow cytometry (FCM) technology. The Expression of microRNA-22 and mRNA levels of its corresponding tumor suppressor gene sirt-1 were analyzed by using QRT-PCR. Results: The apoptosis of glioblastoma cells was markedly enhanced when the concentration of GLA increased (P<0.05 between each group), and there was an inverse correlation between the concentration of GLA used and miR-22 expression tested by QRT-PCR. We also found an increased expression of Sirt-1 in the same treated cells.Conclusion: We conclude that GLA can trigger apoptosis in glioblastoma cells. The mechanisms might be in part due to regulating miR-22 and its corresponding tumor suppressor gene Sirt-1 expression. Our study highlights the potential application of GLA on the anti-cancer therapy of glioblastoma. Keywords: gamma-linolenic acid; apoptosis; glioblastoma; miRNA-22; Sirt-1 S1.40 Anti-tumor effect of annexinA2 monoclonal antibody in vitro Ji-qin NIE, Jian-lin YANG , Wei ZHANG, Chao-qi LIU*. Institute of Molecular Biology of Three Gorges University, Yichang 443002, China * To whom correspondence should be addressed.
Aim: Annexins are a structurally related family of calcium and phospholipidbinding proteins that are involved in the regulation of a range of molecular and cellular processes. To explore the anti-tumor effect of annexinA2 (ANXA2) and its related mechanism, which provide the experimental basis for the tumor treatment in vivo. Methods: pET28a(+)-ANXA2 prokaryotic expressing vector was constructed and the expressed protein was purified, and then it was identified by SDS-PAGE Aim: Celecoxib is a potent nonsteroid anti-inflammatory drug (NSAID) that has demonstrated great promise in cancer chemoprevention and treatment. The goal of this study was to determine the inhibitory effect and mechanism of celecoxib on Lewis lung carcinoma. Methods: The effect of celecoxib on viability of Lewis lung carcinoma cells was assessed with methyl thiazolyl tetrazolium (MTT) assay. Apoptosis and the mitochondrial membrane potential were detected by flow cytometric assay. The protein expression of cytosolic phospholipase A2 (cPLA2), cyclooxygenase-2 (COX-2), and peroxisome proliferator-activated receptor gamma (PPARc) were determined by Western blot analysis. Results: Celecoxib inhibited the proliferation of Lewis lung carcinoma and induced apoptosis in a dosedependent manner by breakdown of mitochondrial membrane potential. The protein expressions of cPLA2 and PPARc were upregulated, but COX-2 protein expression was downregulated in the Lewis lung carcinoma cells exposed to celecoxib. Conclusion: The major findings in this study are that celecoxib could Extract (CASE) on the hepatocarcinogenesis in rats. Methods: Rats were randomly divided into control group, DEN (0.2%, ig ×14 weeks) group, and three dosages groups of CASE (60, 120, or 240 mg/kg, ig ×16 weeks). The rats were sacrificed at 12th week or 16th week after the start of DEN administration. Blood samples were collected for determination liver function. The extent of fibrosis of liver was determined by histopathologic examination. The expression of α-smooth muscle actin (α-SMA) and Glutathione S-transferase protein (GST-P) were detected by immunohistochemistry. PAI-1 transcription activity was analyzed by Real-time RT-PCR. Results: At 12th week, CASE significantly ameliorated the serum parameters of liver function, and decreased the extent of fibrosis and the overexpression of α-SMA. At 16th week, the elevated incidence and multiplicity of hepatoma, and GST-P expression were reduced by CASE treatment. CASE inhibited PAI-1 transcriptional activity in HepG2 cell induced by TGF-β 1 in a dosedependent manner. Corilagin is a novel member of polyphenol family which has been discovered from the medicinal plant Geranium in northeast China. Corilagin nanoparticle is a new physical dosage-form. This study was designed to investigate the effect of corilagin nanoparticle on the apoptosis of SGC-7901 cells. Methods: The cytotoxicity was assessed with SRB assay. The morphological changes were observed by transmission electron microscopy (TEM). The levels of mitochondrial transmembrane potential and ROS were analyzed by Laser confocal scanning microscopy (LCSM). The apoptotic rate was detected by flow cytometry (FCM). The expression of Bcl-2, Bax and Cytochrome c protein were detected by Western blotting, and caspase-3 activity was measured by a microplate reader. Results: The results showed that after treatment with corilagin nanoparticle, the expression of Bcl-2 was down-regulated and Bax was up-regulated compared to that in the control. Corilagin nanoparticle treatment reduced the mitochondrial transmembrane potential, increased the release of cytochrome c and induced caspase 3 activation. Conclusion: Corilagin nanoparticle can inhibit the proliferation of SGC-7901 cells and induce apoptosis via mitochondrial pathway. Keywords: corilagin nanoparticle; human gastric cancer; apoptosis S1.50 A novel apoptosis inducer WF-210 activates procaspase-3 through sequestering inhibitory zinc ions Fang-yang WANG E-mail: yangjingyu2006@gmail.com (Jing-yu YANG); wucf@syphu.edu.cn (Chun-fu WU) Aim: The direct induction of apoptosis has emerged as a powerful anticancer strategy, and small molecules that either inhibit or activate certain proteins in the apoptotic pathway have great potential as novel anticancer drugs. Increased expression of procaspase-3 had been found in numerous tumors. Described herein is the investigation of the effect and mechanism of a novel small compound WF-210. Methods: The procaspase-3 activate activity was detected using a modified molecular docking and enzymatic based in vitro method. The MTT method and Annexin-V/PI co-stain method were used to detect cytotoxic and apoptosis of U-937 cells. Western blot analysis was performed for detecting the expression of apoptosis-related proteins. To further confirm that the apoptosis induced by WF-210 was caspase-3-dependent, chemically synthesized siRNAs was used to silence caspase-3 in HL60 cells with high expression of procaspase-3. Transfection of HL60 cells with siRNAs reduced caspase-3 expression by 60%-70%. Eukaryotic expression plasmid encoding procaspase-3 was transiently transfected into MCF-7 cells which was procaspase-3 deficient. Further study of the procaspase-3 activate mechanism was assayed using recombinant human procaspase-3 protein in buffer with or without zinc. Results: In a modified molecular docking and enzymatic based assay, WF-210 markedly bound and activated procaspase-3 in a concentration-dependent manner with EC 50 (0.85 μmol/L). WF-210 effectively induced apoptosis of U937 cells in a concentration-dependent manner. Cotreatment with different caspase inhibitor and WF-210 partly blocked cell apoptosis. The block rates of van-caspse and caspase-3 inhibitors were higher than caspase-8 and caspase-9 inhibitors. After treatment with WF-210, caspase-3, caspase-8, and caspase-9 were activated in HL60 and U937 cells, and procaspase-3 was activated at first. Silence procaspase-3 gene expression in HL60 could block apoptosis induced by WF-210. Transient transfection of caspase-3 into MCF-7 cells could restore apoptosis induced by WF-210. In further study, WF-210 markedly activated procaspase-3 in a concentration-dependent manner in buffer with zinc, showed no activity in buffer without zinc. Conclusion: Taken together, our results suggest that WF-210 activates procaspase-3 in vitro by sequestering inhibitory zinc ions, and inducing cell apoptosis in a caspase-3 dependent manner. Keywords: Anticancer; Procaspase-3; Apoptosis; ZincS1.51 Flavokawain B, a kava chalcone, induces apoptosis of non-small cell lung cancer by through Bax-initiated mitochondrial pathway Jing WANG, Qi-yu ZHU, Zhe PEI, Zhong-qiu ZENG, Ya-xiong TANG. Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China Aim: Flavokawain B, a chalcone from kava root extracts, possesses strong antineoplastic activity against many cancer cells. Here the antitumor activity and molecular mechanisms in lung cancer cells were investigated. Methods: The anticancer potential of Flavokawain B in lung cancer H460 and A549 cells were tested in vitro. Results: FKB significantly inhibited cell proliferation and caused arrest of the cell cycle G 2 -M in a dose-dependent manner. FKB also inducted apoptosis, which was associated with cytochrome c release, caspase-7 and caspase-9 activation and Bcl-x L /Bax dys-regulation. FKB significantly down-regulated survivin and XIAP, and the inhibitory effect induced by FKB was greatly attenuated by through overexpression of survivin or Bax -/-MEFs. Furthermore, FKB activated the mitogen-activated protein kinases and the JNK inhibitor SP600125 significantly decreased the growth-inhibitory and apoptotic effects of FKB. Conclusion: These results suggest the anti-lung cancer potential of Flavokawain B for the prevention and treatment of lung cancer. Keywords: apoptosis; Bax; Flavokawain B; JNK; lung cancer; survivin Acknowledgements: This work was financially supported by the National Natural Science Foundation of China #81173095 (Ya-xiong TANG) and by the Major Research plan of the National Natural Science Foundation of China #91013006 (Jian SUN).
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Polyamine analogues tetrabutyl propanediamineon induced apoptosis of human leukemia HL-60 Section 1: Antitumor Pharmacology npg E-mail: ccy_ctgu@yahoo.cn Aim: High concentration of polyamines are required for quick proliferation of tumor cells, and an exhaustion in intracellular polyamines will inhibit tumor cell growth and induce apoptosis. Polyamine analogues can promote polyamine degradation and thus to induce apoptosis in tumor cells. Therefor, it necessary to design and develop new polyamine analogues for clinical trail or mechanism research which target polyamine metabolism. In the present study, the impact of a new polyamine analogue, tetrabutyl propanediamine (TBP), on the proliferation and apoptosis of human leukemia HL-60 cells were observed. Methods: HL-60 cells were treated with 50 μmol/L TBP for 24, 48, 72 h. Proliferation rate of HL-60 cells was assayed by MTT. The flow cytometry was performed to identify cell cycle. The DNA fragmentation analysis was used to evaluate apoptosis. Western blot was used to identify the expression of apoptosis-related protein.
Results: TBP dramatically inhibited proliferation of HL-60 cells and the inhibitory effect was in a time and dose dependent manner. The results from flow cytometry analysis indicated that TBP induced cell cycle arrest in G 0 /G 1 . After TBP treatment, typical DNA fragmentation for apoptotic cells was observed by agarose gel electrophoresis. Furthermore, the contents of proapoptotic protein Bax and cytochrome c in the cytosol were significantly increased. Conclusion: TBP can markedly inhibit the proliferation of human leukemia HL60 cells by arresting cell cycle and inducing apoptosis. These results first showed that TBP, as an asymmetric analogue of putrescine, has a potential value in clinical treatment of leukemia. Keywords: polyamines; tetrabutyl propanediamineon; leukemia; apoptosis S1.53 A standardized extract from Paeonia lactiflora and Astragalus membranaceus inhibits proliferation and induces apoptosis in human hepatoma cell lines Jing-jing WU, Shan-shan HU, Sen ZHANG, Wu-yi SUN * , Wei WEI * .
Institute of Clinical Pharmacology, Anhui Medical University, key Laboratory of Anti-inflammatory and Immune Medicine (Anhui Medical University), Ministry of Education, Hefei 230032, China
*To whom correspondence should be addressed. Aims: Paeonia lactiflora and Astragalus membranaceus are two traditional Chinese medicines, commonly used in Chinese herb prescription to treat liver disease. Protective effects of the extract prepared from the roots of Paeonia lactiflora and Astragalus membranaceus (PAE) on liver fibrosis were demonstrated in previous investigations. The present study was designed to investigate whether PAE effect in the growth-inhibition and apoptosis-induction of human hepatoma cell lines HepG2 and SMCC-7721. Methods: After treatment with PAE, the proliferation of HepG2 cells and SMCC-7721 cells was determined by methyl thiazolyl tetrazolium (MTT) and the apoptosis of these two human hepatoma cell lines was measured by flow cytometry with propidium iodide (PI) technology. The expression of Bcl-2, Bax and cleaved caspase-3 was detected by Western blotting, while the expression of Bcl-2 and Bax was also detected by immunohistochemistry. Aim: To observe the effect of extracts from Astragalus membranaceue Bge (AMB) on HepG2 cell and its molecular mechanism. Methods: HepG2 cells were cultured in 2 groups: control group and AMB group; MTT assay and RT-PCR were used to test the variation of the two groups. Results: We observed that the cell population and parapodium of HepG2 decreased transparently in AMB group compared with the control group, and some cell floated. The expression of p53 increased and BclxLdecreased. Conclusion: The extracts of Astragalus membranaceue Bge (AMB) can restrain the growth of HepG2 cell, its mechanism may be the activation of p53 and the suppression of Bcl-x L . Keywords: Astragalus membranaceue Bge; HepG2; Bcl-x L ; p53 S1.57 Investigation of protective effect of Luobuma (Apocynum venetum) extract and its metabolites against tert-butyl hydroperoxide (t-BHP) induced human hepatoma HepG2 cell injury Wen-yan XIE, Xiao-ying ZHANG*. College of Veterinary Medicine, Northwest A&F University, Yangling 712100, China * To whom correspondence should be addressed.
Aims: According to pervious publications, Luobuma (Apocynum venetum) extract showed protective effect for liver damage in in vitro and in vivo models, and the bioactive compounds were considered to be flavonoids that included in Luobuma Section 1: Antitumor Pharmacology npg extract. However, after oral administration, flavonoids are extensively metabolized during absorption, which means only their metabolites instead of the mother flavonoids can reach liver and represent activities. In this work, we investigate the protective effect of Luobuma extract, as well as p-hydroxyphenylacetic acid (p-HPAA) and 3,4-dihydroxyphenylacetic acid (DOPAC) that are two metabolites of its main compounds (hyperoside and quercetin), against tert-Butyl hydroperoxide (t-BHP) induced human hepatoma HepG2 cell injury. Methods: HepG2 cells were per-incubated with Luobuma extract, p-HPAA or DOPAC for 2 or 24 h, and then treated with t-BHP for 3 h. Subsequently, cell viability and alanine aminotransferase (ALT) release were measured by MTT assay and fluorometric assay, respectively. Results: After 2 h pre-incubation, 40-80 μg/mL of Luobuma extract increased 25% cell proliferation and inhibited ALT release by almost 40%, but p-HPAA and DOPAC at tested concentrations showed no effect compared to the control. After 24 h pre-incubation, the protective effect of Luobuma extract was decreased, while DOPAC at concentrations of 0.5-5 μg/mL showed significant stronger beneficial effect compared to the cells treated t-BHP, no obvious change was observed in p-HPAA treated cells. Conclusion: Our results suggest that after biotransformation, Luobuma extract can protect hepatocytes from oxidant attack via its metabolites, which probably act through regulation of specific gene expression since the prolonged protective effect of the metibolites. LIAN) ; zzhang88@zju.edu.cn (Zhi-zhen ZHANG) Aims: Caffeic acid 3,4-dihydroxyphenethyl ester (CADPE) has been reported to possess a broad spectrum of antitumor activity; however, its antitumor mechanism is not well understood. In this study, we investigated the influence of CADPE on cell cycle and its underlying mechanisms using human colorectal cancer cell lines. Methods: First, the anticancer activity of CADPE in human colon cancer cells was determined by measuring the cell growth and the colony formation in the presence or absence of CADPE. Second, the effects of CADPE on cell cycle and the related cell cycle-regulating proteins were analyzed using flow cytometry and Western blot, respectively. Finally, a potential role of p38 MAPK in the anticancer activity of CADPE was explored by using chemical inhibitors of three components of MAPK signaling pathways and determining whether any of the inhibitors was able to abolish or attenuate the CADPE-induced alterations of above parameters. Results: CADPE inhibited cell growth in a variety of human colorectal cancer cell lines with IC 50 values ranging from 4.06 to 17.60 μmol/L, and markedly reduced the colony formation of cancer cell lines. Consistently, CADPE significantly arrested cell cycle progression at G 0 /G 1 phase in measured cell lines with a corresponding and robust decrease in the protein levels of Cdc25A, cyclin A, cyclin D1, cdk2, cdk4, and p-Rb (Ser780), suggesting a crucial role of inhibition of Cdc25A-Cdk2/4-Rb pathway in CADPE-induced cell cycle arrest. Furthermore, CADPE substantially activated p38 MAPK pathway as indicated by a considerable and sustained increase in the level of p-p38 MAPK (Thr180/Tyr182) and the inhibition of p38 MAPK with SB239063 substantially suppressed CADPE-induced arrests of colon cancer cell growth and cell cycle progression as well as CADPE-induced inhibition of Cdc25A-Cdk2/4-Rb pathway, whereas inhibition of ERK1/2 or JNK had no these effects. Conclusion: These results demonstrate that activation of p38 MAPK that leads to inhibition of Cdc25A-Cdk2/4-Rb pathway plays a key role in CADPE-induced cell cycle arrest as well as in the anticancer activity of CADPE. Aim: Tangeretin exhibits anti-proliferative, anti-invasive, anti-metastatic and antioxidant activities under several cancer models in vivo. In this study, we evaluate the effects of tangeretin alone or in combination with 5-FU on cell viability and apoptosis in colon cancer cell lines. Methods: Effects of tangeretin and 5-FU combination or alone on the cell proliferation were tested in colon cancer cells HCT-116 and SW-480 by MTT assay. Iso-bolographic analysis was employed to evaluate the combination effect of tangeretin and 5-FU. Apoptosis in cells were examined by DAPI-staining. The mRNA level of miR-21 (a signature of tumor aggressiveness) was determined by real-time PCR. Two different xenograft studies also used to evaluate the effect of co-administration of tangeretin and 5-FU. Results: Combination of 5-FU and tangeretin has a synergistic effect. Tangeretin at low concentration (25 μg/mL) could markedly enhance the therapeutic effect of 5-FU compared to 5-FU groups (P<0.05). Low concentrations of tangeretin and 5-FU promote apoptosis and decreased mRNA level of miR-21 (P<0.01). In vivo mouse xenograft studies showed that coadmisitration of tangeretin and 5-FU reduced tumor volumes without bodyweight losing. Conclusion: Our data indicate that combination of tangeretin with 5-FU could improve the efficacy of chemotherapy for colon tumors. Keywords: tangeretin; 5-FU; colon cancer; synergistic effect; miR-21 S1.60 Recent advances in anticancer research of homoharringtonine Bin XU. Shanghai Institute of Materia Medica, Chinese Academy of sciences, Shanghai, 200031 , China Homoharringtonine (HHT) was studied in our Institute for many years. In collaboration with other institutions it was proved as an effective antileukemic drug in China in 1978. Afterwards, In our Country HHT was manufactured in several pharmaceutical companies and used clinically as one of basic antitumor drugs approved by Chinese Ministry of Health in 1993. Meanwhile and later, more and more papers were published regarding its action mechanism of antitumor activity and clinical efficacy for treatment of different kinds of leukemias. In recent years in USA, several laboratories and clinical hospitals conducted systematic study on this drug and found some new uses for different malignancies. In particular, HHT is demonstrated as a good therapeutic drug for chronic myelocytic leukemia (CML) including patients who have developed resistance to targeting agents such as imantinib or dasatinib. It attracts much attention from medical circles. In October 2012 FDA approved this drug for treatment of CML patients. Semisynthetic preparation of HHT called omacetaxine mepesuccinate (ceflatonin, CGX-653, Myelostate) has been produced and recommended for clinical application in USA and other countries. When the drug is injected by subcutaneous (SC) route, the bioavailability is excellent. It has been reported that HHT was given as a single agent to 71 patients with late CML-CP (chronic phase of CML) patients at a daily dose of 2.5 mg/m 2 for 14 d during the remission induction phase, and for 7 d monthly during the maintenance phase. A complete hematologic response was obtained by 72%, and cytogenetic respone was achieved by 31%. The major toxicity was myelosuppression. The mechanism of action of omacetaxine is related to the induction of apoptosis in a Bax-independent fashion through mitochondrial disruption and release of cytochrome c, leading to caspase-9 and caspase-3 activation in leukemic cells. Gene expression analysis showed that the transforming growth factor-beta (TGF-β) and the tumor necrosis factor (TNF) signaling pathways appear to play an impotant role in induction of apoptosis by omacetaxine. MTT assay and flow cytometry were used to detect the anti-proliferative effects and cell cycle distribution, respectively. Western blot assay was performed to detect the expression of proteins related to the different cellular signal pathways. Cell adhesion was tested by cell attachments to matrigel and fibronectin using a microscope. Wound healing and transwell assays were employed to investigate cell migration and invasion, respectively. Results: FUR concentration-dependently inhibited cell proliferation and blocked the cell cycle progressions in G 1 phase via down-regulating the protein levels of cyclin D1 and CDK6, and up-regulating those of p21 and p27. FUR also affected the signaling molecules that regulate apoptosis revealed by the down-regulation of the protein levels of PARP, caspase-7, survivin, and the expression ratio of Bcl-2/Bax. Further studies showed that FUR induced expression of light chain 3-II in the protein level, indicating autophagy is involved in this process. However, the adhesive ability of 95-D cells to matrigel and fibronectin was only slightly inhibited after FUR treatment for 1 h. FUR also exhibited slight suppression on cell migration and invasion in 95-D cells. To get enough quantity and quality of DL1106 and its analogue to evaluate their anti-tumor activity, the fermentation conditions of marine actinomycetes REL-3 were optimized. Methods: Estimating the effects of fermentation time and the pH value and salt concentration of fermentation broth on the yield, the fermentation conditions of REL-3 were optimized. After extracting the collection of the fermentation liquid with equal volume of acetic acid ethyl three times, the relative content of the DL1106 and its analogue in the concentrated extracts was detected by HPLC. The crude DL1106 and its analogue were purified by preparative HPLC. The MTT assay was used to evaluate the inhibitory ability of DL1106 and its analogue on the growth of tumor cells, such as A549, HepG2, Skov3 and SY5Y. Results: We got the most objective production until the sixth day in the following fermentation conditions: the salt concentration of fermentation is 2.8% andthe pH value is 7.2. We got DL1106 and its analogue with higher purity. DL1106 and its analogue have strong anti-tumor effect indicated by significant cytotoxicity in A549, HepG2, Skov3, and SY5Y cells. Aim: Based on the molecular and resistance mechanism of alkylating agent temozolomide (TMZ), TMZ analogs's mechanism of action was investigated by in vitro anti-tumor activity assay, cell cycle and apoptosis analysis and DNA damage assay in glioam cells. Methods: the anti-tumor activity of temozolomide analogs was investigated by MTT assay with SNB19, U373 cells and the paired O6-methylguaninemethyltransferase (MGMT) transfected cells lines SNB19M and U373M; also the corresponding acquired resistance glioma cell lines SNB19VR and U373VR and the intrinsic TMZ resistance cell line HCT116 (mismatch repair gene hMLH1 loss) were used as the screening models; the cell cycle analysis of TMZ analog 14112 were performed by flow cytometry in the SNB19V and SNB19M glioma cell lines; DNA double strand breaks (DSBs) induced by 14112 was detected by Western blot and immunofluence with SNB19V and SNB19M cells. In addition, DNA single strand breaks and DNA repair kinetics were analysized by comet assay. Furthermore, the apoptosis caused by 14112 was investigated by PARP antibody in HCT116 cells. Results: TMZ showed highly resistant to MGMT overexpressed cells, however, TMZ analogs were very active in TMZ resistance cell lines, showing equi-activity in the low and high MGMT expressed cells. Analog 14112 showed the most activity in the tested cell lines. Furthermore, TMZ analogs showed anti-tumor activity in the TMZ acquired resistant cell lines SNB19VR and U373VR. Analog 14112 caused cells arrest at G 2 /M and apoptosis. Morevoer, DNA strand breaks was observed with treatment time increased, the excision repair of 14112 was the similar to that of TMZ. The double strand breaks induced by 14112 were earlier than that of TMZ indicated by γH2AX expression. Aim: Jaridonin, a novel ent-kaurane diterpenoid compound from Isodon Rubescens in our laboratory. We designed the current study to determine the effects of Jaridonin on human gastric cancer line MGC-803 autophagy and its possible mechanisms. Methods: After treatment by Jaridonin for 24 h, the effect of Jaridonin on the MGC-803 cell viability was examined using MTT assay. Used the fluorescence
